{"filing":{"accession_number":"0001654954-26-007757","cik":"0001133519","ticker":"MCUJF","company_name":"MEDICURE INC","form":"6-K","filing_date":"2026-08-19","report_date":"2026-08-18","primary_document":"med_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1133519/000165495426007757/med_6k.htm"},"events":[{"id":28558,"run_id":26129,"accession_number":"0001654954-26-007757","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a press release disclosing Medicure's quarterly financial results for the period ended June 30, 2026. The document presents net revenue of $7.4 million, net loss of $1.4 million ($0.14 per share), and adjusted EBITDA of $172,000, along with detailed segment performance and cash position. The filing includes consolidated financial statements (balance sheet, income statement, and cash flow statement) and schedules a conference call to discuss results, which are hallmarks of an earnings release event.","company_name":"MEDICURE INC","ticker":"MCUJF","filing_date":"2026-08-19","form":"6-K","submitted_at":null,"items":[{"id":30543,"accession_number":"0001654954-26-007757","item_number":"EX-99.1","item_title":"med_ex991.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a press release disclosing Medicure's quarterly financial results for the period ended June 30, 2026. The document presents net revenue of $7.4 million, net loss of $1.4 million ($0.14 per share), and adjusted EBITDA of $172,000, along with detailed segment performance and cash position. The filing includes consolidated financial statements (balance sheet, income statement, and cash flow statement) and schedules a conference call to discuss results, which are hallmarks of an earnings release event.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-19T20:35:52.126391+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":30543,"accession_number":"0001654954-26-007757","item_number":"EX-99.1","item_title":"med_ex991.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a press release disclosing Medicure's quarterly financial results for the period ended June 30, 2026. The document presents net revenue of $7.4 million, net loss of $1.4 million ($0.14 per share), and adjusted EBITDA of $172,000, along with detailed segment performance and cash position. The filing includes consolidated financial statements (balance sheet, income statement, and cash flow statement) and schedules a conference call to discuss results, which are hallmarks of an earnings release event.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-19T20:35:52.126391+00:00","company_name":"MEDICURE INC","ticker":"MCUJF","filing_date":"2026-08-19"}]}